Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alpha 2b Plus Ribavirin in Chronic Hepatitis B
NCT00275938Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 1998
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised trial in Chronic Hepatitis B (CHB) comparing Interferon alpha 2b + Ribavirin with Interferon alpha 2b + Placebo (2 arms). Primary endpoint: Undetected serum HBV DNA level. Started Oct 1998; status: completed.
02
Drugs
ribavirin
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00275938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275938.